AI and predictive modeling to understand an individual’s immune system function and predict treatment response are still in very early stages. We dream about precision medicine and getting every answer we can for ourselves when we get sick. However, if we look at genomics, only about 20 percent of human coding genes are well-studied. The remaining 80 percent (about 16,000 genes, along with the proteins they make) are largely a mystery.
In this episode, you will hear more about the field of immuno-oncology, understand the correlation between tumor development and immune system response, and trends in cancer detection and prevention, especially liquid biopsies - tests for detecting tumors in blood samples.
Speaker: Brian Hashemi - Executive Chairman and CEO of Novigenix - a Swiss-based biotech company using AI and RNA sequence analysis to capture the cancer immunity cycle during the multi-stage disease progression and response to therapy.
www.facesofdigitalhealth.com
https://fodh.substack.com/
Show notes:
[00:02:00] The use of AI and RNA sequence analysis in capturing the cancer immunity cycle and disease progression
[00:04:00] Biotech in Switzerland
[00:06:00] The impact of Swiss biotech capabilities on global healthcare and the specific advancements made by Swiss companies in the field.
[00:08:00] Predictions and hopes for the future of healthcare technology, especially in the realms of cancer detection and treatment.
[00:10:00] Challenges and opportunities in biotech, and the role of AI in advancing healthcare.
[00:12:00] Challenges in Colorectal Cancer Screening
[00:14:00] The Impact of Liquid Biopsy on Clinical Trials and Drug Development
[00:16:00] Market Adoption and Patient Accessibility to Liquid Biopsy Tests
[00:18:00] The Future of Liquid Biopsy and Precision Medicine
[00:20:00] Real-world Application and Impact of Novel Biomarkers
[00:22:00] Expanding the Reach of Novel Diagnostics Beyond Switzerland
[00:24:00] Partnerships and Collaborations to Accelerate Adoption
F123 AgeTech Series 3/4: Boosting Empathy In Geriatric Care (Martina Viduka, Advosense)
F122 AgeTech Series 2/4: Algorithm-based Matchmaking Of The Elderly And Caregivers (Anja Silbauer)
F 121 AgeTech Series 1/4: Healthcare and technology in the oldest population in the world - Japan
F120 A Glimpse Into Japan and How to Introduce AI to Clinicians (Adrian Sossna)
F119 How are technologies improving global public health (Dr. Padmini Murthy)
F118 Healthcare is Diverse. Why Is Healthtech Investing Not? (Dr. Fiona Pathiraja)
F117 How Music Beats Got a Breakthrough Device FDA Designation (Brian Harris, MedRythms)
F116 Medication Management Goes Beyond Pill Reminders. Patients Want Transparency. (Jennifer Butler)
F115 Primary care digitalisation in New Zealand, Australia and the USA (Dimitri Varsamis)
F114 “My hope is we will mispronounce COVID in ten years” (John Nosta)
F 113 Predictions about 2021 (and beyond) by digital health experts from the US, Israel, Mexico, Chile, UK, Italy and South Korea
F112 How is regenerative medicine disrupting the MedTech industry (Frank Barry)
F111 The full circle in telemedicine - adding home delivery of medications and at-home diagnostics ( Sid Viswanathan, Truepill)
F110 "Patient records on the blockchain are still a dream" (Robert Miller)
109 How digitally healthy is New Zealand? (Scott Arrol)
F108 What's the value of telehealth consultations for doctors and patients? (Julian Flannery)
F107 AI driven health insurance (Rajeev Ronanki, Anthem)
F106 VRx book discussion: What 5000 studies taught us about the healing power of VR? (Dr. Brennan Spiegel)
Australia: The state of healthcare digitalization (Louise Schaper, AIDH)
F104 Digital health in Spain and what is the concept of a liquid hospital? (Cesar Morcillo Serra)
Create your
podcast in
minutes
It is Free
Insight Story: Tech Trends Unpacked
Zero-Shot
Fast Forward by Tomorrow Unlocked: Tech past, tech future
The Unbelivable Truth - Series 1 - 26 including specials and pilot
Lex Fridman Podcast